Over 30 million biomedical articles have been published to date, and 100,000 new articles are added every month - – which makes it time-consuming and inefficient to try to decipher the connections hidden within, and emerging discoveries can easily be missed.
Causaly’s mission is to transform how humans can find, visualise and interpret biomedical knowledge. Our artificial intelligence platform builds on in-house proprietary Natural Language Understanding technology, which is reading and understanding biomedical literature similarly to how humans do- only Causaly has read everything ever written in biomedicine and can visualise relevant cause-and effect relationships within seconds. Important decisions can quickly be supported by all available evidence to date, where previously literature reviews could take weeks or even months..
Causaly is headquartered in London and is working with industry, governments and academia in healthcare and life sciences to enable faster, higher quality and more transparent decision-making based on evidence. Causaly’s platform can be used for a broad array of applications by various functions - e.g. Drug Discovery, Drug Safety, Clinical Trials, Epidemiology, Health Economics, Market Access, Medical Affairs, Pharmacovigilance, Business Development and IP & Patents.